R
Riccardo Schiavina
Researcher at University of Bologna
Publications - 400
Citations - 7561
Riccardo Schiavina is an academic researcher from University of Bologna. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 41, co-authored 304 publications receiving 6094 citations. Previous affiliations of Riccardo Schiavina include University of Southern California.
Papers
More filters
Journal ArticleDOI
Complications After Systematic, Random, and Image-guided Prostate Biopsy
Marco Borghesi,Hashim U. Ahmed,Robert K. Nam,Edward M. Schaeffer,Riccardo Schiavina,Samir S. Taneja,Wolfgang Weidner,Stacy Loeb +7 more
TL;DR: Complications after prostate biopsy are frequent but often self-limiting, and transperineal and in-bore MRI-targeted biopsy may reduce the risk of severe infectious complications.
Journal Article
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
Mohsen Farsad,Riccardo Schiavina,Paolo Castellucci,Cristina Nanni,Barbara Corti,Giuseppe Martorana,Romeo Canini,Walter F. Grigioni,Stefano Boschi,Mario Marengo,Cinzia Pettinato,Eugenio Salizzoni,Nino Monetti,Roberto Franchi,Stefano Fanti +14 more
TL;DR: The data do not support the routine use of PET/CT with (11)C-choline as a first-line screening procedure for prostate cancer in men at high risk, and it is found that prostatic disorders other than cancer may accumulate.
Journal ArticleDOI
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Riccardo Schiavina,Vincenzo Scattoni,Paolo Castellucci,Maria Picchio,Barbara Corti,Alberto Briganti,Alessandro Franceschelli,Francesco Sanguedolce,Alessandro Bertaccini,M. Farsad,Giampiero Giovacchini,Stefano Fanti,Walter F. Grigioni,Ferruccio Fazio,Francesco Montorsi,Patrizio Rigatti,Giuseppe Martorana +16 more
TL;DR: In patients with intermediate-risk and high-risk PCa, C-Choline PET/CT has quite a low sensitivity for LNM detection but performed better than clinical nomograms, with equal sensitivity and better specificity.
Journal ArticleDOI
18 F-FACBC (anti1-amino-3- 18 F-fluorocyclobutane-1-carboxylic acid) versus 11 C-choline PET/CT in prostate cancer relapse: results of a prospective trial
Cristina Nanni,Lucia Zanoni,Cristian Vincenzo Pultrone,Riccardo Schiavina,Eugenio Brunocilla,Filippo Lodi,Claudio Malizia,Matteo Ferrari,Patrizio Rigatti,Cristina Fonti,Giuseppe Martorana,Stefano Fanti +11 more
TL;DR: 18F-FACBC can be considered an alternative tracer superior to 11C-choline in the setting of patients with biochemical relapse after radical prostatectomy and presenting with rising PSA.
Journal ArticleDOI
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
Claudia Testa,Riccardo Schiavina,Raffaele Lodi,Eugenio Salizzoni,Barbara Corti,Mohsen Farsad,John Kurhanewicz,Fabio Manferrari,Eugenio Brunocilla,Caterina Tonon,Nino Monetti,Paolo Castellucci,Stefano Fanti,Manuela Coe,Walter F. Grigioni,Giuseppe Martorana,Romeo Canini,Bruno Barbiroli +17 more
TL;DR: In localizing cancer within the prostate, comparable specificity was obtained with either 3D MR spectroscopy and MR imaging or PET/ CT; however, PET/CT had lower sensitivity relative to3D MR Spectroscopy alone or combined with MR imaging.